GLPwatch
Adlyxin for Depression
lixisenatide · Investigational / off-label
Last updated 2026-05-28 15:46 UTCAdlyxin (lixisenatide) is not FDA-approved for depression, and any use for this condition is off-label or investigational. Research in mice suggests intranasal lixisenatide may reduce emotional and olfactory symptoms of depression by enhancing neurogenesis, but this has not been confirmed in humans.
AI summary of the sources below.
| Drug | Adlyxin (lixisenatide) |
|---|---|
| Condition | Depression |
| Approval status | Investigational / off-label |
| Research papers | 2 |
Adlyxin is not FDA-approved for depression; the research below reflects investigational or off-label study only.